Thesis Abstract

Abstract
Cancer remains one of the leading causes of mortality globally, necessitating the continuous exploration of innovative treatment strategies to enhance therapeutic outcomes and minimize adverse effects. The development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach to address the limitations of conventional treatments. This thesis aims to investigate the design, development, and evaluation of advanced drug delivery systems tailored for targeted cancer therapy. The introduction sets the stage by providing an overview of the challenges associated with current cancer treatment modalities and the potential benefits of targeted drug delivery systems. The background of the study delves into the existing literature on drug delivery systems, highlighting the need for personalized and site-specific cancer therapies. The problem statement underscores the gaps in current cancer treatment approaches and the need for more effective and less toxic alternatives. The objectives of the study encompass the design and optimization of novel drug delivery systems capable of targeted drug delivery to cancer cells while minimizing off-target effects. The limitations and scope of the study are outlined to provide a clear understanding of the research boundaries and constraints. The significance of the study emphasizes the potential impact of developing advanced drug delivery systems in improving cancer treatment outcomes and patient quality of life. The literature review chapter provides a comprehensive analysis of existing drug delivery systems for cancer therapy, focusing on their mechanisms of action, advantages, and limitations. Key aspects such as nanoparticle-based drug delivery, liposomes, micelles, and polymer-based carriers are critically evaluated to identify gaps in current research and areas for further exploration. The research methodology chapter details the experimental procedures and methodologies employed in designing and evaluating novel drug delivery systems. Key aspects such as formulation development, characterization techniques, in vitro and in vivo studies, and data analysis methods are described to ensure the rigor and reproducibility of the research findings. The discussion of findings chapter presents a detailed analysis of the experimental results, including drug release profiles, cellular uptake studies, cytotoxicity assays, and in vivo efficacy assessments. The implications of the findings are discussed in the context of advancing the field of targeted cancer therapy and addressing the challenges associated with conventional treatment approaches. In conclusion, this thesis contributes to the field of cancer therapy by demonstrating the feasibility and potential benefits of novel drug delivery systems for targeted cancer treatment. The study highlights the importance of personalized medicine and precision oncology in optimizing therapeutic outcomes and reducing treatment-related toxicities. Future research directions and implications for clinical translation are discussed to guide further advancements in the field of targeted drug delivery for cancer therapy.

Thesis Overview